Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Linda, Nici"'
Autor:
Roger Goldstein, José R. Jardim, Linda Nici, Jonathan Raskin, Martijn A. Spruit, Richard ZuWallack
Publikováno v:
Breathe, Vol 20, Iss 2 (2024)
Externí odkaz:
https://doaj.org/article/58da3092e3804c7c88d940a8e8f45691
Autor:
Clarice Y. Tang, Bruce Bernstein, Felicity Blackstock, Astrid Blondeel, Andrea Gershon, Elena Gimeno-Santos, Rainer Gloeckl, Alda Marques, Martijn A. Spruit, Chris Garvey, Mike Morgan, Linda Nici, Sally J. Singh, Thierry Troosters
Publikováno v:
Breathe, Vol 20, Iss 2 (2024)
Exercise limitation and physical inactivity are known treatable traits for people with COPD. Maximising exercise capacity and keeping people physically active improves health status and survival rates among people with COPD. However, managing these t
Externí odkaz:
https://doaj.org/article/a1f4114f86ee4615973134c6afcf14ab
Autor:
Anouk W. Vaes, Chris Burtin, Richard Casaburi, Bartolome R. Celli, Rachael A. Evans, Suzanne C. Lareau, Linda Nici, Carolyn L. Rochester, Thierry Troosters
Publikováno v:
Breathe, Vol 20, Iss 2 (2024)
Exercise limitation and physical inactivity are separate, but related constructs. Both are commonly present in individuals with COPD, contribute to disease burden over and above the respiratory impairments, and are independently predictive of adverse
Externí odkaz:
https://doaj.org/article/b305f48661634f19b1b6410511bd97c1
Publikováno v:
Medicina, Vol 57, Iss 7, p 726 (2021)
Medical management of a chronic obstructive pulmonary disease (COPD) patient must incorporate a broadened and holistic approach to achieve optimal outcomes. This is best achieved with integrated care, which is based on the chronic care model of disea
Externí odkaz:
https://doaj.org/article/55d9e669d90b4f7c9cab570af3cea56e
Publikováno v:
Lung. 199:653-657
British Thoracic Society (BTS) guidelines recommend using the Herder model to risk-stratify lung nodules after positron emission tomography (PET). However, this approach has not been adequately evaluated, particularly among Veterans. A single-center
Autor:
Deborah E Klein, Linda Nici, Scott Coggeshall, Laura C. Feemster, Paul Krebs, Hannah Johnson, Steven B. Zeliadt, Jaimee L. Heffner, Chelle L Wheat
Publikováno v:
J Gen Intern Med
BACKGROUND: Implementation of effective smoking cessation interventions in lung cancer screening has been identified as a high-priority research gap, but knowledge of current practices to guide process improvement is limited due to the slow uptake of
Publikováno v:
Monaldi Archives for Chest Disease, Vol 87, Iss 2 (2017)
Traditional, outpatient pulmonary rehabilitation provided to stable COPD patients leads to significant improvements in dyspnea, exercise capacity and health related quality of life. Also, when started during or shortly after a hospitalization for a C
Externí odkaz:
https://doaj.org/article/45c8d22b9d7e4a06937f01ae2c66df03
Autor:
Linda Nici, Manoj J. Mammen, Sunita Mulpuru, Joseph K. Ruminjo, Carey C. Thomson, Shawn D. Aaron, Paul E. Alexander, Eric J. Gartman
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Background: This document provides clinical recommendations for the pharmacologic treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative effort on the part of a panel of expert COPD clinicians and researchers along w
Autor:
Anum S. Ahmed, Rajesh Kunadharaju, David R. Lloyd, Sandeep Kumar, Manoj J. Mammen, Paul E. Alexander, Linda Nici, Shawn D. Aaron, Shilpi Gupta, Vandana Pai
Publikováno v:
Annals of the American Thoracic Society. 17:1308-1318
Rationale: There is uncertainty on the use of using triple therapy (inhaled corticosteroids/long-acting β-agonist/long-acting muscarinic antagonist) inhaler therapy for patients with chronic obstru...
Autor:
Paul E. Alexander, Linda Nici, Vandana Pai, Waleed Alhazzani, Shawn D. Aaron, Manoj J. Mammen
Publikováno v:
Annals of the American Thoracic Society. 17:1133-1143
Rationale: There is uncertainty on the optimal first-line therapy for symptomatic chronic obstructive pulmonary disease (COPD). Long-acting β2-receptor agonists (LABAs) and long-acting muscarinic a...